EP4121007
HIGH CONCENTRATION ANTI-AMYLOID BETA PEPTIDE PROTOFIBRIL ANTIBODY FORMULATIONS AND METHODS OF USE THEREOF
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
19.3.2021:
2.7.2025:
21722538.2
:
18.3.2041:
18.3.2026
:
HIGH CONCENTRATION ANTI-AMYLOID BETA PEPTIDE PROTOFIBRIL ANTIBODY FORMULATIONS AND METHODS OF USE THEREOF
19.3.2021
2.7.2025
18.3.2026
:
Eisai R&D Management Co., Ltd.:
6-10 Koishikawa, 4-Chome Bunkyo-Ku, Tokyo 112-8088, JP
:
YOSHIDA, Nobuo:
Tokyo 112--8088, JP
:
SAKURAMOTO, Naomi:
Kakamigahara-shi, Gifu 501--6195, JP
:
SAKAGUCHI, Takahisa:
Kakamigahara-shi, Gifu 501--6195, JP
:
KITO, Hirokazu:
Kakamigahara-shi, Gifu 501--6195, JP
:
OZAWA, Takahiro:
Kakamigahara-shi, Gifu 501--6195, JP
:
JOSHI, Anjali:
Cary, North Carolina 27519, US
:
HSU, Yung Yueh:
Carlisle, Massachusetts 01741, US
:
SOUILLAC, Pierre:
Winchester, Massachusetts 01890, US
:
202062992746 P:
20.3.2020:
US
:
202063027263 P:
19.5.2020:
US
:
IB2021000155:
19.3.2021
:
A61K 9/00, A61K 39/00, A61K 47/12, A61K 47/18, A61K 47/26